Baxter Healthcare (Enlon product line)
M&A
STATUS
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
A portfolio of pharmaceutical products. The enlon product line includes edrophonium chloride injection, edrophonium chloride, atropine sulphate, ampule recommended for the diagnosis of myasthenia.
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- One Baxter Parkway
- Deerfield, IL 60015
- United States
Baxter Healthcare (Enlon product line) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Baxter Healthcare (Enlon product line)‘s full profile, request access.
Request full access to PitchBookBaxter Healthcare (Enlon product line) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Baxter Healthcare (Enlon product line)‘s full profile, request access.
Request full access to PitchBook